The largest database of trusted experimental protocols

Acquity ultra performance liquid chromatography

Manufactured by Waters Corporation
Sourced in United States, United Kingdom

The ACQUITY ultra performance liquid chromatography (UPLC) system is a laboratory instrument designed for high-resolution separation and analysis of complex samples. It utilizes advanced technology to provide efficient and rapid chromatographic separations, enabling enhanced resolution, sensitivity, and speed compared to traditional HPLC systems.

Automatically generated - may contain errors

96 protocols using acquity ultra performance liquid chromatography

1

NMR Spectroscopy and UPLC/MS Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
1H- and 13C- NMR spectra were acquired on a Bruker DRX-500 spectrometer. Chemical shift δ is expressed in parts per million, with the solvent resonance as an internal standard (CDCl3, 1H: 7.26; 13C: 77.16 ppm; DMSO-d6, 1H: 2.50 ppm; 13C: 39.52 ppm). NMR data are reported as follows: chemical shift, multiplicity (br = broad, d = doublet, q = quartet, m = multiplet, s = singlet, t = triplet), coupling constant, and integration. All reactions in aprotic solvents were performed under argon in oven-dried glassware. Reaction progress was monitored on a Waters Acquity Ultra Performance Liquid Chromatography (UPLC/MS). All HPLC purifications were performed on a Waters Autopure (mass directed purification system) equipped with a Prep C18 5μm OBD (19 × 150 mm) column. High Resolution Mass Spectra (HRMS) of final products were collected on a PE SCIEX API 100. Unless otherwise stated, all commercially available materials were purchased from Aldrich, P3 BioSystems, Combi-Blocks or other vendors and were used as received. The purity of all final compounds were > 95% as determined on a Waters Acquity Ultra Performance Liquid Chromatography (UPLC/MS) using the following method: gradient (5–95% ACN + 0.1% formic acid in water + 0.1% formic acid over 7.5 min, followed by 95% ACN + 0.1% formic acid for 0.5 min); flow rate 0.3 mL/min, column ACQUITY UPLC® BEH C18 1.7μM (2.1 × 50mm).
+ Open protocol
+ Expand
2

Metabolomic Analysis of Organic Anion Transporters

Check if the same lab product or an alternative is used in the 5 most similar protocols
Individual, unpooled samples were measured by the Metabolon analytical system (Metabolon, Inc., Durham, NC)60 (link), 61 (link). Samples were prepared and subjected to ultrahigh performance liquid chromatography-tandem mass spectroscopy (UPLC-MS/MS) utilizing an ACQUITY ultra-performance liquid chromatography (UPLC) (Waters, Milford, MA) and a Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution (Thermo Scientific, Waltham, MA). Raw data was extracted, peak-identified and QC processed using Metabolon’s hardware and software60 (link), 61 (link). Two-way ANOVA testing was used to calculate the p-values and the metabolites that were selected for display in figures and tables had either: (1) a fold change ≥1.2 with a p-value ≤ 0.05; or (2) a fold change ≥2.0 with a p-value ≤ 0.1 in at least one of the various comparisons (e.g., Oat1KO vs WT; Oat3KO vs WT; Oat3KO + probenecid vs Oat3KO). The separability of the uremic toxins/retention solutes in the wildtype, Oat3KO, and probenecid-treated Oat3KO plasma samples was assessed by partial least squares discriminant analysis (PLS-DA) using Metaboanalyst 3.0 (http://www.metaboanalyst.ca/)62 (link).
+ Open protocol
+ Expand
3

Characterization of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 1

Unless otherwise stated, all commercially available materials were purchased from Bachem, Aldrich, P3 BioSystems, or other vendors and were used as received. All non-aqueous reactions were performed under argon in oven-dried glassware. Routine monitoring of reactions was performed using Waters Acquity Ultra Performance Liquid Chromatography (UPLC). All HPLC purifications were done by Varian PrepStar HPLC system or Waters Autopure (mass directed purification system) using Prep C18 5 μm OBD (19×150 mm) column. 1H- and 13C-NMR spectra were acquired on a Bruker DRX-500 spectrometer. Chemical shifts 6 are expressed in parts per million, with the solvent resonance as an internal standard (chloroform-d, 1H: 7.26; 13C: 77.16 ppm; DMSO-d6, 1H: 2.50 ppm; 13C: 39.52 ppm). Hexafluorobenzene was used as internal standard for 19F NMR. NMR data are reported as following: chemical shift, multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet, br=broad), coupling constant, and integration.

+ Open protocol
+ Expand
4

Quantification of Vitamin D Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vitamin D metabolites were extracted from donor serum (0.2 mL) or placental tissue homogenates as described previously [26 ]. Resulting samples were reconstituted in 125 μL water/methanol (50/50%) for LC-MS/MS analysis as previously described [26 ] using a Waters ACQUITY ultra performance liquid chromatography [uPLC] coupled to a Waters Xevo TQ-S mass spectrometer [Waters, Manchester, UK]). Analysis was carried out in multiple reaction monitoring (MRM) mode, with optimised MRM transitions for each analyte as described previously [26 ]. External quality control (QC) samples (LGC Standards, Teddington, UK) for 25(OH) D3 and 25(OH)D2 were used to assess accuracy and precision within batch runs. QCs across different concentration ranges to determine inter- and intra-day accuracy and precision for each analyte were as described previously [26 ]. Data analysis was performed with Waters Target Lynx.
+ Open protocol
+ Expand
5

Comprehensive Metabolomic Analysis Pipeline

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the four platforms utilized an ACQUITY Ultra-Performance Liquid Chromatography (UPLC) (Waters, Milford, USA) and a Q Exactive™ Hybrid Quadrupole-Orbitrap™ mass spectrometer interfaced with heated electrospray ionization (HESI-II) source (ThermoFisher Scientific, Waltham, Massachusetts, USA). The sample extracts were reconstituted in solvents compatible to each of the four LC-MS methods: two separated reverse phase UPLC-ESI(+)MS/MS methods optimized for hydrophilic and hydrophobic compounds; one reverse phase UPLC-(−)MS/MS using basic optimized conditions; and one HILIC/UPLC-(−)MS/MS. The MS analysis alternated between full scan MS and data-dependent MSn scans using dynamic exclusion. The scan range for both ionization modes was 70–1000 m/z.
+ Open protocol
+ Expand
6

Quantification of Serum 25OHD Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Both total and free 25OHD were quantified from collected mouse sera. Free 25OHD analysis was performed using enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions (Diasource, cat no: KAPF1991). This assay has 77% cross-reactivity with 25D2. Total serum 25OHD was analysed using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as described previously, with slight modifications [20 (link), 21 ]. In brief, samples were prepared for analysis by protein precipitation and supported liquid-liquid extraction (SLE). Samples were derivatized with 4-(2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalinyl)ethyl)-1,2,4-triazoline-3,5-dione (DMEQ-TAD) as previously described [22 (link)]. Analysis of serum was performed on a Waters ACQUITY ultra performance liquid chromatography (UPLC) coupled to a Waters Xevo TQ-XS mass spectrometer. The LC-MS/MS method has been validated on US Food and Drug Administration guidelines for analysis of these metabolites as previously described (32).
+ Open protocol
+ Expand
7

UPLC-MS/MS Quantification of Venlafaxine and its Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Acquity ultra-performance liquid chromatography (UPLC, Waters Corp., Milford, MA, USA) system was used for analysis. Separation by chromatography was achieved by an Acquity BEH C18 column (2.1 mm × 50 mm, 1.7 μm) at 45 °C. The gradient elution solutions were water with 0.1% formic acid (A) and acetonitrile (B). The following gradient protocol was used: 0–0.5 mins (90-90% A), 0.5–1.0 mins (90-10% A), 1.0–2.0 mins (10-10% A), 2.0–2.1 mins (10-90% A), 2.1–3.0 min (90-90% A). The total run time was set at 3.0 mins and 0.40 mL/min was the flow rate.
Mass spectrometric measurement was achieved on a XEVO TQ-S triple quadrupole mass spectrometer with an electrospray ionization (ESI) interface in positive ionization mode. Quantification was achieved by multiple reaction monitoring (MRM) mode with transitions of m/z 278.1 → 58.1 for venlafaxine, m/z 264.2 →58.1 for ODV, m/z 264.2 → 147.0 for NDV and m/z 285.0 → 154.0 for IS, respectively. Data acquisition and control of instrument were done by Masslynx 4.1 software (Waters Corp., Milford, MA, USA).
+ Open protocol
+ Expand
8

Recombinant Protein Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffers, antibiotics and bacterial growth media were obtained from Fisher Scientific (Pittsburg, PA) and Sigma-Aldrich (St. Louis, MO). Turbo BL21 (DE3) chemically competent cells were obtained from Genlantis (San Diego, CA) and pVP55A vector was obtained from the Center for Eukaryotic Structural Genomics at the University of Wisconsin-Madison [17 (link)]. For protein purification, immobilized metal affinity chromatography (IMAC) was used in an AKTA prime system from GE Healthcare (Chicago, IL). Acquity ultra-performance liquid chromatography (UPLC) and Amide (1.7 μm, 2.1 mm × 100 mm) analytical columns were obtained from Waters Co. (Milford MA). NADPH was obtained from EMD Biosciences (Billerica, MA). UDP-Galf was synthesized as described previously [13 (link)]. Kinase Inhibitor Library (L1200) was obtained from Selleckchem (Houston, TX). The fluorescence thermal shift assay was performed in an RT-PCR (Applied Biosystems 7300) using 96-well RT-PCR plates (Microamp 4306737) and optical adhesive films (MicroAmp 431197971). Isothermal titration calorimetry (ITC) measurements were performed in Auto-ITC 200 from Malvern Instruments (Alvern, UK) and analyzed using the Microcal Origin version 7.0 (OriginLab). Flavopiriol was purchased from ApexBio (Houston, TX).
+ Open protocol
+ Expand
9

IgG Glycan Analysis by HILIC-UPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescently labeled IgG glycans were analyzed by hydrophilic interaction liquid chromatography (HILIC) on an Acquity Ultra-Performance Liquid Chromatography (UPLC) instrument (Waters, Milford, MA, USA), as previously described in detail [44 (link)]. The obtained UPLC chromatograms were all separated in the same manner into 24 peaks and the amount of glycans in each peak was expressed as a percentage of the total integrated area. The glycan structures corresponding to each individual peak were determined previously [44 (link)].
+ Open protocol
+ Expand
10

Profiling Plasma Amino Acid Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were taken for AA profile analysis after 3.5–5.5 hours of fasting by puncture of the mandibular vein at week 6 and 12 during diet treatment. Plasma was isolated by centrifugation at 3000 × g for 10 min at 4 °C and stored at -80 °C prior to analysis. A small pilot study was performed to validate the test.
Analysis of free AA in plasma was carried out using a Waters Acquity Ultra-Performance Liquid Chromatography (UPLC) (Waters) system with an integrated photodiode array detector and the Mass Trak AA Solution Kit (Waters) according to standard protocols with the slight modifications described by Peake et al [29 (link)]. All conditions are available upon request.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!